Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1128|34|3|644-675

ISSN： 0198-6325

Source： MEDICINAL RESEARCH REVIEWS, Vol.34, Iss.3, 2014-05, pp. : 644-675

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Human Poly(ADP‐Ribose) Polymerase‐1 with Natural Medicines and Its Potential Applications in Ovarian Cancer Therapeutics

By  

ARCHIV DER PHARMAZIE (ELECTRONIC), Vol. 348, Iss. 11, 2015-11 ,pp. : 817-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of ADP ribosylation in PARP‐1 and bacterial toxins using a capillary‐based western system

By  

ELECTROPHORESIS, Vol. 36, Iss. 21-22, 2015-12 ,pp. : 2798-2804

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications

By  

MEDICINAL RESEARCH REVIEWS, Vol. 35, Iss. 2, 2015-03 ,pp. : 225-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modifications to Increase the Efficiency of the Fluorometric Cycling Assay for Cyclic ADP-Ribose

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 9, Iss. 8, 2006-09 ,pp. : 633-637

Bentham Science Publishers

Access to resources Recommend Favorite

Chromatographic and adsorption properties of the mixed stationary phase poly(1-trimethylsilyl-1-propyne)/poly(1-phenyl-1-propyne)

By Yakovleva E.   Belotserkovskaya V.  

Journal of Analytical Chemistry, Vol. 66, Iss. 6, 2011-06 ,pp. : 629-633

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite